Medical Design & Outsourcing

Compremium’s Quantis CVP is a breakthrough for noninvasive cardiac pressure measurement

Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) ...
Yahoo Finance

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program

MURI BEI BERN, Switzerland, January 20, 2026--(BUSINESS WIRE)--Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel ...
Medical Xpress

POCUS measure of JVP predicts elevated CVP in heart failure

(HealthDay)—For patients undergoing right heart catheterization, point-of-care ultrasonography assessment of the jugular venous pressure (JVP) height can accurately predict elevated central venous ...
Morningstar

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Program

Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel solution designed to directly measure central venous pressure ...
Finanznachrichten

Compremium AG: Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA's TAP Program

Novel solution aims to transform clinical pathways for critical hemodynamic monitoring Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...